Varian, Inc. Acquires Oxford Diffraction, Ltd.
News Apr 11, 2008
Varian, Inc. has announced it has acquired Oxford Diffraction, Ltd., a privately owned company based in Abingdon, UK. Oxford Diffraction is a leader in x-ray crystallography, and analytical technique used by scientists in pharmaceutical research and other research labratories to determine the structure of both small and large molecules such as proteins.
For crystalline compounds, x-ray crystallography is the most powerful technique available for structural analysis. Nuclear magnetic resonance (NMR) provides complementary structural information for compounds in the solid state and also structural information for compounds in solutions.
"The acquisition of Oxford Diffraction is key to Varian's goal of broadening it's range of information-rich detection products for life science research" said Garry W. Rogerson, President and CEO, Varian, Inc. "Oxford Diffraction has experienced rapid growth since its formation in 2001 and has established a strong reputation in single crystal X-ray crystallography, particularly in Europe. Oxford Diffraction products will now be distributed on a global basis via Varian's worldwide distribution network."
"In addition to the obvious benefit to our business of a much larger distribution and support organization, the sale of Oxford Diffraction to Varian brings a number of additional important advantages," said Paul Loeffen, CEO of Oxford Diffraction. "We now have the opportunity to offer customers more powerful solutions through combinations of complementary information-rich techniques to include X-ray crystallography, nuclear magnetic resonance spectrometry and liquid chromatography-mass spectrometry (LC-MS). Furthermore, as part of Varian, we look forward to continuing the development of innovative technologies and products for our customers."
"Existing Oxford Diffraction customers will continue to benefit from the same dedicated and attentive customer support and applications team at Oxford Diffraction but with the additional resources of Varian's worldwide support organization," said David Warner, Customer Support Group Manager at Oxford Diffraction. "One of our strengths has been a tailored and personal support experience for our customers. This will not change since our customers will be dealing with the same people. The support of the Varian network will simply enhance this experience."
Varian, Inc. acquired Oxford Diffraction for approximately $37 million in cash and assumed net debt (subject to certain net asset adjustments). The transaction also includes an opportunity for additional purchase price payments over 3 years, dependent on future financial performance. Those future payments could total up to $10 million if aggressive performance targets are achieved. Oxford Diffraction generated revenues of approximately $15 million for the twelve months ended March 31, 2008. Varian, Inc. will provide further details on the acquisition during its webcast conference call to review its fiscal year 2008 second quarter financial results later this month.
This acquisition is part of Varian, Inc.'s strategy to strenghen the company's portfolio of information-rich detection products, through internal research and development as well as the acquisition of complementary products and technologies.
Test For Designer Drugs Could Help Treat Overdose PatientsNews
Medical professionals are scrambling to meet the growing demand for emergency room treatment, but they’re hampered by the lack of a quick and easy test to screen patients for “designer” drugs. Chemists have now developed such a test and are refining it with the hope that hospitals could eventually use it to choose the appropriate treatment.READ MORE
Comet "Chury's" Late BirthNews
Comets which consist of two parts, like Chury, can form after a catastrophic collision of larger bodies. Such collisions may have taken place in a later phase of our solar system, which suggests that Chury can be much younger than previously assumed. This is shown through computer simulations.READ MORE
Comments | 0 ADD COMMENT
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018